D
2.72
-0.05 (-1.81%)
| Previous Close | 2.77 |
| Open | 2.72 |
| Volume | 425,737 |
| Avg. Volume (3M) | 1,078,031 |
| Market Cap | 293,659,360 |
| Price / Earnings (Forward) | 12.95 |
| Price / Sales | 1.26 |
| Price / Book | 0.660 |
| 52 Weeks Range | |
| Earnings Date | 8 May 2025 |
| Profit Margin | -163.81% |
| Operating Margin (TTM) | 0.53% |
| Diluted EPS (TTM) | -3.54 |
| Quarterly Revenue Growth (YOY) | -5.50% |
| Total Debt/Equity (MRQ) | 41.69% |
| Current Ratio (MRQ) | 2.30 |
| Operating Cash Flow (TTM) | 58.20 M |
| Levered Free Cash Flow (TTM) | 71.64 M |
| Return on Assets (TTM) | -0.42% |
| Return on Equity (TTM) | -65.49% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Definitive Healthcare Corp. | Bearish | Bearish |
AIStockmoo Score
0.3
| Analyst Consensus | -1.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.25 |
|
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution. Geographically, it derives a majority of its revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 7.60% |
| % Held by Institutions | 99.06% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Advent International, L.P. | 31 Dec 2024 | 62,493,676 |
| Palisade Capital Management, Lp | 31 Mar 2025 | 2,265,198 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 3.00 (Goldman Sachs, 10.29%) | Hold |
| 3.00 (Barclays, 10.29%) | Sell | |
| Median | 3.00 (10.29%) | |
| Average | 3.00 (10.29%) | |
| Total | 1 Hold, 1 Sell | |
| Avg. Price @ Call | 2.81 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Goldman Sachs | 04 Mar 2025 | 3.00 (10.29%) | Hold | 2.78 |
| Barclays | 03 Mar 2025 | 3.00 (10.29%) | Sell | 2.83 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 24 Apr 2025 | Announcement | Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast |
| 04 Apr 2025 | Announcement | Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) |
| 04 Mar 2025 | Announcement | Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) |
| 27 Feb 2025 | Announcement | Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024 |
| 25 Feb 2025 | Announcement | Definitive Healthcare to Present at the Raymond James 2025 Institutional Investors Conference |
| 13 Feb 2025 | Announcement | Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |